Merck (MRK) concluded the recent trading session at $110.18, signifying a -1.7% move from its prior day's close.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $144.12, ...

Merck (MRK) is one of the worst-performing stocks in the Dow Jones Industrial Average (DJIA) on Thursday. The US government ...

The pharmaceutical industry plays a crucial role in most of our everyday lives. From life-saving medication we need when we ...

Ethereum, or 1 ETH, traded at $2,352.32 as of 8 a.m. ET. The highest intraday price the cryptocurrency reached in the past ...

The best performers of the session on the Dow Jones Industrial Average were International Business Machines (NYSE: IBM ), ...

Pharmaceutical companies are demonstrating innovation by not only developing new drugs but also exploring combination therapies and ...

The benefits do not stop there. Recent studies suggest GLP-1 drugs may also reduce the risk of heart disease, kidney disease and stroke, and even possibly protect the brain from AD by reducing ...

U.S. equities were lower at the close on Thursday, as losses in the Consumer Goods, Basic Materials and Healthcare sectors ...

The Centers for Medicare & Medicaid Services (CMS) has added several changes to the Medicare price negotiation process ...

As of 2:56 PM EDT. Market Open.

Wells Fargo analysts presented their “Core” list of stocks. These are high-quality, “blue chip, industry-leading companies.” ...